Clinical Trial Type: Biliary Tract

Name of this trial: Destiny-BTC What type of cancer is this for? Biliary Tract Cancer Who is this trial for? First line for locally advanced or metastatic HER2 expressing biliary tract cancer What biomarkers are involved? HER2 positive (expressing) What is the National Clinical Trial #? NCT06467357   Brief summary of this trial: Phase 3